Dr. Mohamed Al-Sayed Al-Shabrawey discusses his ongoing research on new therapeutic targets for diabetic retinopathy at Duphat 2025. With diabetes affecting millions globally, and a significant percentage developing diabetic retinopathy, there is an urgent need for innovative solutions. Dr. Al Shabrawey talks about promising therapies like bone morphogenic protein and the rapid growth of artificial intelligence in ophthalmology, shaping the future of eye care.

#MedEdgeMEA #DiabeticRetinopathy #Ophthalmology #AIInHealthcare #ResearchInnovation #Duphat2025

Also watch : Pediatric Hematology & Cancer Care | Dr. muhammad faisal khanani | BMT